Product Name

  • Name

    Norepinephrine

  • EINECS 200-096-6
  • CAS No. 51-41-2
  • Article Data12
  • CAS DataBase
  • Density 1.397 g/cm3
  • Solubility Soluble in alkali and dilute hydrochloric acid. Slightly soluble in water, ethanol and diethyl ether.
  • Melting Point 220-230 °C
  • Formula C8H11NO3
  • Boiling Point 442.6 °C at 760 mmHg
  • Molecular Weight 169.18
  • Flash Point 221.5 °C
  • Transport Information UN 2811 6.1/PG 2
  • Appearance Off-white to tan solid
  • Safety 28-36/37-45-36/37/39-26-16
  • Risk Codes 26/27/28-34-11
  • Molecular Structure Molecular Structure of 51-41-2 (Norepinephrine)
  • Hazard Symbols VeryT+,CorrosiveC,FlammableF
  • Synonyms 1,2-Benzenediol,4-(2-amino-1-hydroxyethyl)-, (R)-;Arterenol, l- (6CI);Benzyl alcohol, a-(aminomethyl)-3,4-dihydroxy-,(-)- (8CI);(-)-Arterenol;(-)-Noradrenaline;(-)-Norepinephrine;(-)-a-(Aminomethyl)protocatechuylalcohol;(R)-(-)-Norepinephrine;(R)-Noradrenaline;(R)-Norepinephrine;4-((1R)-2-Amino-1-hydroxyethyl)-1,2-benzenediol;Adrenor;Aktamin;Arterenol;Levoarterenol;Levonor;Levonorepinephrine;Levophed;Nor-Epirenan;Norartrinal;Sympathin E;l-1-(3,4-Dihydroxyphenyl)-2-aminoethanol;l-2-Amino-1-(3,4-dihydroxyphenyl)ethanol;l-3,4-Dihydroxyphenylethanolamine;l-Arterenol;
  • PSA 86.71000
  • LogP 0.79020

Synthetic route

arterenone
499-61-6

arterenone

norepinephrine
51-41-2

norepinephrine

Conditions
ConditionsYield
Stage #1: arterenone With (-)-diisopinocampheylboron chloride In tert-butyl methyl ether at -25 - -20℃; for 3h; Inert atmosphere;
Stage #2: With hydrogenchloride In tert-butyl methyl ether; water at 25℃; for 1.5h; Catalytic behavior; Reagent/catalyst; Solvent; Temperature; Inert atmosphere;
70.3%
R-(+)-2,2'-dinitrobiphenyl-6,6'-dicarbonsaeure-di-N,N'-1-(3,4-dihydroxyphenyl)-1-hydroxy-2-amido-ethan
104819-57-0, 104873-30-5, 104873-31-6

R-(+)-2,2'-dinitrobiphenyl-6,6'-dicarbonsaeure-di-N,N'-1-(3,4-dihydroxyphenyl)-1-hydroxy-2-amido-ethan

norepinephrine
51-41-2

norepinephrine

Conditions
ConditionsYield
With hydrogenchloride; hydrogen; palladium on activated charcoal In ethanol for 6h; Ambient temperature;51.4%
Norepinephrine
138-65-8

Norepinephrine

norepinephrine
51-41-2

norepinephrine

Conditions
ConditionsYield
With MANDELIC ACID
With (R)-methoxyphenylacetic acid
With L-Tartaric acid
glycine
56-40-6

glycine

3,4-dihydroxybenzaldehyde
139-85-5

3,4-dihydroxybenzaldehyde

A

norepinephrine
51-41-2

norepinephrine

B

D-noradrenaline
149-95-1

D-noradrenaline

Conditions
ConditionsYield
With pyridoxal 5'-phosphate In dimethyl sulfoxide at 20℃; for 89h; Enzymatic reaction; Title compound not separated from byproducts.;
1-(3,4-dihydroxyphenyl)-1-oxo-2-amino-ethan-hydrochlorid
5090-29-9

1-(3,4-dihydroxyphenyl)-1-oxo-2-amino-ethan-hydrochlorid

norepinephrine
51-41-2

norepinephrine

Conditions
ConditionsYield
Multi-step reaction with 3 steps
1: 61.4 percent / NaHCO3 / benzene; H2O / 30 h
2: NaBH4 / methanol / 24 h
3: 51.4 percent / H2, conc HCl / Pd/C / ethanol / 6 h / Ambient temperature
View Scheme
R-(+)-2,2'-dinitrobiphenyl-6,6'-dicarbonsaeure-di-N,N'-1-(3,4-dihydroxyphenyl)-1-oxo-2-amido-ethan
104819-55-8, 104873-27-0, 104873-28-1

R-(+)-2,2'-dinitrobiphenyl-6,6'-dicarbonsaeure-di-N,N'-1-(3,4-dihydroxyphenyl)-1-oxo-2-amido-ethan

norepinephrine
51-41-2

norepinephrine

Conditions
ConditionsYield
Multi-step reaction with 2 steps
1: NaBH4 / methanol / 24 h
2: 51.4 percent / H2, conc HCl / Pd/C / ethanol / 6 h / Ambient temperature
View Scheme
L-tyrosine
60-18-4

L-tyrosine

norepinephrine
51-41-2

norepinephrine

Conditions
ConditionsYield
Multi-step reaction with 3 steps
1: tetrahydrobiopterin; oxygen; tyrosine hydroxylase / Enzymatic reaction
2: aromatic L-amino acid decarboxylase / Enzymatic reaction
3: oxygen; dopamine β-hydroxylase; ascorbic acid / Enzymatic reaction
View Scheme
levodopa
59-92-7

levodopa

norepinephrine
51-41-2

norepinephrine

Conditions
ConditionsYield
Multi-step reaction with 2 steps
1: aromatic L-amino acid decarboxylase / Enzymatic reaction
2: oxygen; dopamine β-hydroxylase; ascorbic acid / Enzymatic reaction
View Scheme
dopamine
51-61-6

dopamine

norepinephrine
51-41-2

norepinephrine

Conditions
ConditionsYield
With dopamine β-hydroxylase; oxygen; ascorbic acid Enzymatic reaction;
C14H21N4O3(1+)*Cl(1-)

C14H21N4O3(1+)*Cl(1-)

norepinephrine
51-41-2

norepinephrine

Conditions
ConditionsYield
With hydrogenchloride In water at 20℃; for 10h;6.8 g
2-chloro-3',4'-dihydroxyacetophenone
99-40-1

2-chloro-3',4'-dihydroxyacetophenone

norepinephrine
51-41-2

norepinephrine

Conditions
ConditionsYield
Multi-step reaction with 3 steps
1: (R)-α,α-diphenylprolinol; sodium tetrahydroborate; chloro-trimethyl-silane / tetrahydrofuran / 24 h / 10 - 30 °C / Inert atmosphere
2: N,N-dimethyl-formamide / 18 h / 85 °C
3: hydrogenchloride / water / 10 h / 20 °C
View Scheme
C8H9ClO3

C8H9ClO3

norepinephrine
51-41-2

norepinephrine

Conditions
ConditionsYield
Multi-step reaction with 2 steps
1: N,N-dimethyl-formamide / 18 h / 85 °C
2: hydrogenchloride / water / 10 h / 20 °C
View Scheme
Norepinephrine
138-65-8

Norepinephrine

A

norepinephrine
51-41-2

norepinephrine

B

D-noradrenaline
149-95-1

D-noradrenaline

Conditions
ConditionsYield
With phase-transitioned bovine serum albumin film-coated capillary column In methanol pH=8; Resolution of racemate;
L-Tartaric acid
87-69-4

L-Tartaric acid

norepinephrine
51-41-2

norepinephrine

C8H11NO3*C4H6O6*H2O

C8H11NO3*C4H6O6*H2O

Conditions
ConditionsYield
With water In ethanol at 20℃; for 12h;96.7%
formaldehyd
50-00-0

formaldehyd

norepinephrine
51-41-2

norepinephrine

1,2,3,4-tetrahydro-4,6,7-isoquinolinetriol hydrochloride
41462-32-2

1,2,3,4-tetrahydro-4,6,7-isoquinolinetriol hydrochloride

Conditions
ConditionsYield
With hydrogenchloride at 24℃; for 24h;92%
norepinephrine
51-41-2

norepinephrine

3-<<4-<(tert-butyldimethylsilyl)oxy>phenyl>acetyl>thiazolidine-2-thione
130120-90-0

3-<<4-<(tert-butyldimethylsilyl)oxy>phenyl>acetyl>thiazolidine-2-thione

2-[4-(tert-Butyl-dimethyl-silanyloxy)-phenyl]-N-[(R)-2-(3,4-dihydroxy-phenyl)-2-hydroxy-ethyl]-acetamide
130097-10-8

2-[4-(tert-Butyl-dimethyl-silanyloxy)-phenyl]-N-[(R)-2-(3,4-dihydroxy-phenyl)-2-hydroxy-ethyl]-acetamide

Conditions
ConditionsYield
In N,N-dimethyl-formamide at 25℃;82%
norepinephrine
51-41-2

norepinephrine

1-(2-Thioxo-thiazolidin-3-yl)-hexadecan-1-one
74058-64-3

1-(2-Thioxo-thiazolidin-3-yl)-hexadecan-1-one

N-hexadecanoyl-L-noradrenaline
74064-89-4, 94475-55-5

N-hexadecanoyl-L-noradrenaline

Conditions
ConditionsYield
In tetrahydrofuran; ethanol for 5h; Ambient temperature;51%
2-(2-methoxyphenoxy)-ethyl methanesulphonate
122853-43-4

2-(2-methoxyphenoxy)-ethyl methanesulphonate

norepinephrine
51-41-2

norepinephrine

trifluoroacetic acid
76-05-1

trifluoroacetic acid

(R)-4-(1-hydroxy-2-((2-(2-methoxyphenoxy)ethyl)amino)ethyl)benzene-1,2-diol trifluoroacetate

(R)-4-(1-hydroxy-2-((2-(2-methoxyphenoxy)ethyl)amino)ethyl)benzene-1,2-diol trifluoroacetate

Conditions
ConditionsYield
Stage #1: 2-(2-methoxyphenoxy)-ethyl methanesulphonate; norepinephrine In dimethyl sulfoxide at 70℃; for 6h; Inert atmosphere;
Stage #2: trifluoroacetic acid In methanol; water; dimethyl sulfoxide
46%
norepinephrine
51-41-2

norepinephrine

3-methoxy-4-(3-phenylpropoxy)phenethyl methanesulfonate

3-methoxy-4-(3-phenylpropoxy)phenethyl methanesulfonate

trifluoroacetic acid
76-05-1

trifluoroacetic acid

(R)-4-(1-hydroxy-2-((3-methoxy-4-(3-phenylpropoxy)phenethyl)amino)ethyl)benzene-1,2-diol trifluoroacetate

(R)-4-(1-hydroxy-2-((3-methoxy-4-(3-phenylpropoxy)phenethyl)amino)ethyl)benzene-1,2-diol trifluoroacetate

Conditions
ConditionsYield
Stage #1: norepinephrine; 3-methoxy-4-(3-phenylpropoxy)phenethyl methanesulfonate In dimethyl sulfoxide at 70℃; for 6h; Inert atmosphere;
Stage #2: trifluoroacetic acid In methanol; water; dimethyl sulfoxide Inert atmosphere;
38%
nicotinic anhydride
16837-38-0

nicotinic anhydride

norepinephrine
51-41-2

norepinephrine

N-nicotinoylnorepinephrine

N-nicotinoylnorepinephrine

Conditions
ConditionsYield
In tetrahydrofuran; methanol at 20℃; for 20h;37%
norepinephrine
51-41-2

norepinephrine

N-{4-[4-(4-oxopiperidin-1-yl)phenylsulfamoyl]phenyl}acetamide
373359-53-6

N-{4-[4-(4-oxopiperidin-1-yl)phenylsulfamoyl]phenyl}acetamide

N-(4-{[4-(4-{[(2R)-2-(3,4-dihydroxyphenyl)-2-hydroxyethyl]amino}-1-piperidinyl)anilino]sulfonyl}phenyl)acetamide

N-(4-{[4-(4-{[(2R)-2-(3,4-dihydroxyphenyl)-2-hydroxyethyl]amino}-1-piperidinyl)anilino]sulfonyl}phenyl)acetamide

Conditions
ConditionsYield
With hydrogen; palladium on activated charcoal In ethanol under 258.574 - 1034.3 Torr;15%
norepinephrine
51-41-2

norepinephrine

5-azidopentan-2-one
84702-73-8

5-azidopentan-2-one

1-(R)-(3.4-dihydroxyphenyl)-2-(1-methyl-4-azidobutylamino)ethanol oxalate salt
186303-33-3

1-(R)-(3.4-dihydroxyphenyl)-2-(1-methyl-4-azidobutylamino)ethanol oxalate salt

Conditions
ConditionsYield
15%
norepinephrine
51-41-2

norepinephrine

acetic anhydride
108-24-7

acetic anhydride

A

4-[bis-(1H-5,6-diacetoxyindol-2-yl)methyl]-1,2-diacetoxybenzene

4-[bis-(1H-5,6-diacetoxyindol-2-yl)methyl]-1,2-diacetoxybenzene

B

3,4-diacetoxybenzaldehyde
67727-64-4

3,4-diacetoxybenzaldehyde

C

5,6-diacetoxyindole
15069-79-1

5,6-diacetoxyindole

D

1-acetyl-3,5,6-triacetoxyindole

1-acetyl-3,5,6-triacetoxyindole

Conditions
ConditionsYield
Stage #1: norepinephrine With sodium periodate; phosphate buffer In water for 0.0833333h; pH=7.4;
Stage #2: acetic anhydride With pyridine
A 7%
B 1%
C 1%
D 3%
C18H32O4
5503-03-7

C18H32O4

norepinephrine
51-41-2

norepinephrine

C26H41NO8
1036406-97-9

C26H41NO8

Conditions
ConditionsYield
With oxygen; tris hydrochloride In water; dimethyl sulfoxide at 25℃; for 15h; pH=8.0; regioselective reaction;6%
C18H30O3

C18H30O3

norepinephrine
51-41-2

norepinephrine

C26H39NO7
1036407-01-8

C26H39NO7

Conditions
ConditionsYield
With oxygen; tris hydrochloride In water; dimethyl sulfoxide at 25℃; for 15h; pH=8.0; regioselective reaction;2%
10-oxo-cis-12-octadecenoic acid
155168-72-2

10-oxo-cis-12-octadecenoic acid

norepinephrine
51-41-2

norepinephrine

C26H41NO7
1036407-00-7

C26H41NO7

Conditions
ConditionsYield
With oxygen; tris hydrochloride In water; dimethyl sulfoxide at 25℃; for 15h; pH=8.0;2%
3-pyridinecarbonyl chloride
10400-19-8

3-pyridinecarbonyl chloride

norepinephrine
51-41-2

norepinephrine

N-nicotinoylnorepinephrine

N-nicotinoylnorepinephrine

Conditions
ConditionsYield
With pyridine
norepinephrine
51-41-2

norepinephrine

(R)-2-acetylamino-1-(3,4-dimethoxy-phenyl)-ethanol
26630-36-4

(R)-2-acetylamino-1-(3,4-dimethoxy-phenyl)-ethanol

Conditions
ConditionsYield
durch Acetylierung und Umsetzung des Reaktionsprodukts mit Diazomethan;
norepinephrine
51-41-2

norepinephrine

noradrenochrome
490-89-1

noradrenochrome

Conditions
ConditionsYield
With methanol; silver(l) oxide
norepinephrine
51-41-2

norepinephrine

chloroformic acid ethyl ester
541-41-3

chloroformic acid ethyl ester

((R)-3,4,β-trihydroxy-phenethyl)-carbamic acid ethyl ester
99161-02-1, 103565-71-5

((R)-3,4,β-trihydroxy-phenethyl)-carbamic acid ethyl ester

norepinephrine
51-41-2

norepinephrine

acetic anhydride
108-24-7

acetic anhydride

(R)-2-acetylamino-1-(3,4-diacetoxy-phenyl)-ethanol
28371-32-6

(R)-2-acetylamino-1-(3,4-diacetoxy-phenyl)-ethanol

norepinephrine
51-41-2

norepinephrine

salicylaldehyde
90-02-8

salicylaldehyde

(R)-N-salicylidenenorepinephrine
73428-22-5

(R)-N-salicylidenenorepinephrine

Conditions
ConditionsYield
With ethanol
In methanol
norepinephrine
51-41-2

norepinephrine

6-oxoheptanoic acid p-methylanilide
83086-06-0

6-oxoheptanoic acid p-methylanilide

6-[(E)-(R)-2-(3,4-Dihydroxy-phenyl)-2-hydroxy-ethylimino]-heptanoic acid p-tolylamide
90900-18-8

6-[(E)-(R)-2-(3,4-Dihydroxy-phenyl)-2-hydroxy-ethylimino]-heptanoic acid p-tolylamide

Conditions
ConditionsYield
With 3 A molecular sieve In N,N-dimethyl-formamide at 75℃; for 24h;
norepinephrine
51-41-2

norepinephrine

6-oxo-N-<4-(trifluoromethyl)phenyl>heptanamide
84417-40-3

6-oxo-N-<4-(trifluoromethyl)phenyl>heptanamide

A

6-[(E)-(R)-2-(3,4-Dihydroxy-phenyl)-2-hydroxy-ethylimino]-heptanoic acid (4-trifluoromethyl-phenyl)-amide
90900-17-7

6-[(E)-(R)-2-(3,4-Dihydroxy-phenyl)-2-hydroxy-ethylimino]-heptanoic acid (4-trifluoromethyl-phenyl)-amide

B

6-[(R)-2-(3,4-Dihydroxy-phenyl)-2-hydroxy-ethylamino]-hept-6-enoic acid (4-trifluoromethyl-phenyl)-amide

6-[(R)-2-(3,4-Dihydroxy-phenyl)-2-hydroxy-ethylamino]-hept-6-enoic acid (4-trifluoromethyl-phenyl)-amide

Conditions
ConditionsYield
With 3 A molecular sieve In N,N-dimethyl-formamide at 75℃; for 24h; Title compound not separated from byproducts;
norepinephrine
51-41-2

norepinephrine

homovanillic acid
130097-16-4

homovanillic acid

2-[4-(tert-Butyl-dimethyl-silanyloxy)-3-methoxy-phenyl]-N-[(R)-2-(3,4-dihydroxy-phenyl)-2-hydroxy-ethyl]-acetamide

2-[4-(tert-Butyl-dimethyl-silanyloxy)-3-methoxy-phenyl]-N-[(R)-2-(3,4-dihydroxy-phenyl)-2-hydroxy-ethyl]-acetamide

Conditions
ConditionsYield
In N,N-dimethyl-formamide at 25℃;
norepinephrine
51-41-2

norepinephrine

acetaldehyde
75-07-0

acetaldehyde

trans-1,2,3,4-tetrahydro-1-methyl-4,6,7-isoquinolinetriol hydrochloride
85507-49-9

trans-1,2,3,4-tetrahydro-1-methyl-4,6,7-isoquinolinetriol hydrochloride

cis-1,2,3,4-tetrahydro-1-methyl-4,6,7-isoquinolinetriol hydrochloride
85507-48-8

cis-1,2,3,4-tetrahydro-1-methyl-4,6,7-isoquinolinetriol hydrochloride

Conditions
ConditionsYield
With hydrogenchloride for 36h; Product distribution; with formaldehyde, var. pH;
With hydrogenchloride for 36h; Yield given. Yields of byproduct given;
norepinephrine
51-41-2

norepinephrine

4-diethylaminodiazobenzene-4'-isothiocyanate
204763-28-0

4-diethylaminodiazobenzene-4'-isothiocyanate

1-[4-(4-Diethylamino-phenylazo)-phenyl]-3-[(R)-2-(3,4-dihydroxy-phenyl)-2-hydroxy-ethyl]-thiourea

1-[4-(4-Diethylamino-phenylazo)-phenyl]-3-[(R)-2-(3,4-dihydroxy-phenyl)-2-hydroxy-ethyl]-thiourea

Conditions
ConditionsYield
With acetic acid; triethylamine In acetone Addition; Heating;
norepinephrine
51-41-2

norepinephrine

A

(R)-3',4'-dihydroxyphenylglycol

(R)-3',4'-dihydroxyphenylglycol

B

(R)-3',4'-dihydroxymandelic acid

(R)-3',4'-dihydroxymandelic acid

Conditions
ConditionsYield
With Krebs solution; monoamine oxidase in lung of rat Kinetics; Further Variations:; Catalysts; Deamination;
norepinephrine
51-41-2

norepinephrine

water
7732-18-5

water

ethylenediamine
107-15-3

ethylenediamine

air

air

1,2,3,4-tetrahydropyrazino[2,3-g]quinoxaline
28857-14-9

1,2,3,4-tetrahydropyrazino[2,3-g]quinoxaline

Conditions
ConditionsYield
pH 11;

Norepinephrine Specification

The l-Norepinephrine with CAS registry number of 51-41-2 is also known as Noradrenalina. The IUPAC name is 4-[(1R)-2-Amino-1-hydroxyethyl]benzene-1,2-diol. It belongs to product categories of Chiral. Its EINECS registry number is 200-096-6. In addition, the formula is C8H11NO3 and the molecular weight is 169.18. This chemical is a off-white to tan solid and should be stored in sealed containers with protection of argon and away from light at the temperature of 4 °C.

Physical properties about l-Norepinephrine are: (1)ACD/LogP: -0.88; (2)# of Rule of 5 Violations: 1 ; (3)#H bond acceptors: 4; (4)#H bond donors: 5; (5)#Freely Rotating Bonds: 6; (6)Index of Refraction: 1.659; (7)Molar Refractivity: 44.63 cm3; (8)Molar Volume: 121 cm3; (9)Surface Tension: 76.7 dyne/cm; (10)Density: 1.397 g/cm3; (11)Flash Point: 221.5 °C; (12)Enthalpy of Vaporization: 73.79 kJ/mol; (13)Boiling Point: 442.6 °C at 760 mmHg; (14)Vapour Pressure: 1.3E-08 mmHg at 25 °C.

Preparation of l-Norepinephrine. The reaction has two steps. Firstly, collar hydroquinone is mixed with chloroacetyl chloride to generate 3,4-dihydroxy-2-chloro acetophenone. Secondly, the reactant reacts with Ammonia or methenamine to obtain the product.

Uses of l-Norepinephrine: it is used to produce 1,2,3,4-tetrahydro-4,6,7-isoquinolinetriol hydrochloride by reaction with formaldehyde. The reaction occurs with reagent 1M HCl at 24 °C for 24 hours. The yield is about 92%. What's more, it is used to as vasoactive drug of anti-shock.

l-Norepinephrine is used to produce 1,2,3,4-tetrahydro-4,6,7-isoquinolinetriol hydrochloride by reaction with formaldehyde.

When you are using this chemical, please be cautious about it. As a chemical, it is very toxic by inhalation, in contact with skin and if swallowed. What's more, it is highly flammable that may cause burns. During using it, wear suitable protective clothing, gloves and eye/face protection. Avoid contact with skin and eyes. Keep away from sources of ignition. After contact with skin, wash immediately. If contact with eyes accidently, rinse immediately with plenty of water and seek medical advice. In case of accident or if you feel unwell seek medical advice immediately.

You can still convert the following datas into molecular structure:
1. Canonical SMILES: C1=CC(=C(C=C1C(CN)O)O)O
2. Isomeric SMILES: C1=CC(=C(C=C1[C@H](CN)O)O)O
3. InChI: InChI=1S/C8H11NO3/c9-4-8(12)5-1-2-6(10)7(11)3-5/h1-3,8,10-12H,4,9H2/t8-/m0/s1
4. InChIKey: SFLSHLFXELFNJZ-QMMMGPOBSA-N

The toxicity data is as follows:

Organism Test Type Route Reported Dose (Normalized Dose) Effect Source
mouse LD50 intraperitoneal 6mg/kg (6mg/kg)   Drugs in Japan Vol. 6, Pg. 567, 1982.
mouse LD50 intravenous 550ug/kg (0.55mg/kg)   Naunyn-Schmiedeberg's Archiv fuer Experimentelle Pathologie und Pharmakologie. Vol. 226, Pg. 493, 1955.
mouse LD50 oral 20mg/kg (20mg/kg)   Acta Pharmacologica et Toxicologica. Vol. 31, Pg. 49, 1972.
mouse LD50 subcutaneous 5mg/kg (5mg/kg)   Naturwissenschaften. Vol. 56, Pg. 615, 1969.
rabbit LDLo intravenous 250ug/kg (0.25mg/kg)   Archives Internationales de Pharmacodynamie et de Therapie. Vol. 41, Pg. 365, 1931.
rat LD50 intravenous 100ug/kg (0.1mg/kg) BEHAVIORAL: SOMNOLENCE (GENERAL DEPRESSED ACTIVITY)

BEHAVIORAL: MUSCLE WEAKNESS

LUNGS, THORAX, OR RESPIRATION: DYSPNEA
Journal of Pharmacology and Experimental Therapeutics. Vol. 95, Pg. 502, 1949.

Post buying leads

About|Contact|Cas|Product Name|Molecular|Country|Encyclopedia

Message|New Cas|MSDS|Service|Advertisement|CAS DataBase|Article Data|Manufacturers | Chemical Catalog

©2008 LookChem.com,License: ICP

NO.:Zhejiang16009103

complaints:service@lookchem.com Desktop View